CompletedNot Applicable

Safety and Efficacy of Long-term Somatropin Treatment in Children

Germany5,442 participantsStarted 2001-01

Plain-language summary

This study is conducted in Europe. The aim of this study is to evaluate safety during the long-term use of somatropin (Norditropin®) in children as well as efficacy on change in height. A subgroup of children small for their gestational age is included.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * In need of somatropin or current user

What they're measuring

Number of adverse events

Timeframe: Up to 10 years

Trial details

NCT IDNCT01543867

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2011-12

View on ClinicalTrials.gov More Growth Hormone Disorder trials